Future work should integrate tumor microenvironment profiling, such as tumor-infiltrating lymphocytes (TILs), PD-L1 expression, and spatial transcriptomics, to contextualize systemic immune signatures and validate serum biomarkers with intratumoral correlates. Here, CD274 is linked to neoplasm.